BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28976821)

  • 1. Lost in translation? Accountability and governance of clinical stem cell research in China.
    Zhang JY
    Regen Med; 2017 Sep; 12(6):647-656. PubMed ID: 28976821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New regulation for clinical stem cell research in China: expected impact and challenges for implementation.
    Rosemann A; Sleeboom-Faulkner M
    Regen Med; 2016 Jan; 11(1):5-9. PubMed ID: 26680327
    [No Abstract]   [Full Text] [Related]  

  • 3. China's science, technology, engineering, and mathematics (STEM) research environment: A snapshot.
    Han X; Appelbaum RP
    PLoS One; 2018; 13(4):e0195347. PubMed ID: 29614123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International institutions and China's health policy.
    Huang Y
    J Health Polit Policy Law; 2015 Feb; 40(1):41-71. PubMed ID: 25480846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. China's Insurance Regulatory Reform, Corporate Governance Behavior and Insurers' Governance Effectiveness.
    Li H; Zhang H; Tsai SB; Qiu A
    Int J Environ Res Public Health; 2017 Oct; 14(10):. PubMed ID: 29039781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. China's health assistance to Africa: opportunism or altruism?
    Lin S; Gao L; Reyes M; Cheng F; Kaufman J; El-Sadr WM
    Global Health; 2016 Dec; 12(1):83. PubMed ID: 27912773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. China and the global stem cell bioeconomy: an emerging political strategy?
    Salter B; Cooper M; Dickins A
    Regen Med; 2006 Sep; 1(5):671-83. PubMed ID: 17465734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding China's growing involvement in global health and managing processes of change.
    Husain L; Bloom G
    Global Health; 2020 May; 16(1):39. PubMed ID: 32357894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scientific institutions and effective governance: a case study of Chinese stem cell research.
    Zhang JY
    New Genet Soc; 2011 Jun; 30(2):193-207. PubMed ID: 24143127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review and challenges of policies of environmental protection and sustainable development in China.
    Zhang KM; Wen ZG
    J Environ Manage; 2008 Sep; 88(4):1249-61. PubMed ID: 17767999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards Holistic Governance of China's E-Waste Recycling: Evolution of Networked Policies.
    Yang X; Miao X; Wu J; Duan Z; Yang R; Tang Y
    Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33053709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research on Human Embryos and Reproductive Materials: Revisiting Canadian Law and Policy.
    Ogbogu U; Zarzeczny A; Baltz J; Bedford P; Du J; Hyun I; Jaafar Y; Jurisicova A; Kleiderman E; Koukio Y; Knoppers BM; Leader A; Master Z; Nguyen MT; Noohi F; Ravitsky V; Toews M
    Healthc Policy; 2018 Feb; 13(3):10-19. PubMed ID: 29595433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rethink the patentability of human embryonic stem cell research findings: Relaxation based on benefit weighing.
    Chen J; Li W
    Stem Cell Reports; 2021 Aug; 16(8):1868-1873. PubMed ID: 34380021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social Management of Gender Imbalance in China: A Holistic Governance Framework.
    Shuzhuo L; Zijuan S; Feldman MW
    Econ Polit Wkly; 2013 Aug; 48(35):79-86. PubMed ID: 26663948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organizing forestry governance: Cadre training in China's multi-level governance regime.
    Marinaccio J
    J Environ Manage; 2019 Feb; 231():795-803. PubMed ID: 30415172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reflection on the governance of clinical stem cell research and applications in China.
    Chen H
    Regen Med; 2017 Sep; 12(6):593-597. PubMed ID: 28976281
    [No Abstract]   [Full Text] [Related]  

  • 17. Understanding China's dam-induced resettlement under the institutionalised governance process of policy coevolution.
    Zhang Y
    J Environ Manage; 2021 Apr; 283():111968. PubMed ID: 33497886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. China's health system: determinants.
    Lyle KC
    Am J Chin Med; 1980; 8(3):199-220. PubMed ID: 7211741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Stem Cell Technology in Malaysia: Current Status and Recommendations.
    Gopalan N; Nor SNM; Mohamed MS
    Sci Eng Ethics; 2020 Feb; 26(1):1-25. PubMed ID: 31123979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. China's evolving biosafety/biosecurity legislations.
    Cao C
    J Law Biosci; 2021; 8(1):lsab020. PubMed ID: 34221436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.